CCI approves GSK, Pfizer consumer healthcare JV formation

After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2VXdi6e
via Latest News of India